| Catalog Number: | 10683-RBM12-NF647-100T |
|---|---|
| Gene: | |
| Host: | |
| Reactivity: |
Trial Size Available
Carrier-Free Available

| Document Name | |
|---|---|
| Datasheet | Download Here |
| Material Safety Data Sheet | Download Here |
| Applications | Tested Dilutions | Protocol | Note |
|---|---|---|---|
| Flow Cytometry (Flow) | 1-2ug/million cells | Flow Cytometry Protocol | |
| Immunohistochemistry (IHC) | 1-2ug/ml | IHC Protocol | 30 min at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes |
| Western Blot (WB) | 2-4ug/ml | Western Blot Protocol |
The LIN-12/Notch family of transmembrane receptors is believed to play a central role in development by regulating cell fate decisions. Notch can be activated by several ligands including Jagged1, Jagged2 and the Delta family of proteins. Delta-3, also known as DLL3 (Drosophila Delta homolog 3) or SCDO1, is a single-pass type I membrane protein that can bind to and activate Notch receptors. Required to divert neurons along their specified differentiation pathways, Delta-3 can inhibit primary neurogenesis and assist in forming somite boundaries during paraxial mesoderm segmentation. Delta-3 contains six EGF-like domains, one transmembrane domain and one DSL domain which is required for proper binding to the Notch receptor. Ubiquination by Skeletrophin (also known as MIB2, mindbomb homolog 2) leads to endocytosis and subsequent degradation of Delta-3. Defects in the gene encoding Delta-3 are the cause of autosomal recessive spondylocostal dysostosis type 1 (SCDO1), a condition characterized by rib fusions and multiple hemivertebrae.
Should a NeoBiotechnologies antibody not meet the experimental expectations outlined on our website or datasheet, please contact our Technical Support. We unconditionally guarantee our product.
Our team of scientists are ready to help you with expert recommendations or technical assistance related to applications or product use.
NeoBiotechnologies develops and manufactures
highly specific, validated monoclonal antibodies
for cancer research and diagnostics.
© 2026 NeoBiotechnologies. All Rights Reserved.
Monday-Friday: 8:00am – 8:00pm Pacific Time